[Eubacterium rectale]


Eubacterium rectale: A Key Butyrate-Producing Gut Commensal

Introduction

Eubacterium rectale is a prominent member of the human gut ecosystem, recognized primarily as one of the most abundant butyrate-producing bacteria in the colon. As a key component of the Firmicutes phylum, this microbe plays a vital role in maintaining the symbiotic balance between the host and the microbiome. Through the fermentation of dietary fibers, E. rectale contributes to the production of short-chain fatty acids (SCFAs), which are essential for gut barrier integrity and the modulation of the host's immune response. Understanding the functional potential of this microbe provides critical insights into preventive health and the management of microbial balance.

Location of Microbe

Gut Ecosystem

Eubacterium rectale is primarily located within the large intestine, where it specifically colonizes the mucin layer. This strategic positioning allows it to interact closely with the colonic mucosa and the intestinal epithelium.

Behavior During Dysbiosis

Microbial Depletion

During states of dysbiosis, Eubacterium rectale is frequently depleted. A marked reduction in its abundance is associated with decreased fecal and plasma SCFA levels, which can disrupt metabolic balance and impair the gut-kidney axis, potentially contributing to the formation of calcium oxalate kidney stones.

Impact of External Stressors

Environmental and biological stressors can trigger its decline. For instance, infection with Strongyloides stercoralis in patients with chronic kidney disease is associated with a significant reduction in the abundance of this species, contributing to an overall loss of microbial diversity.

Disease Associations

Metabolic and Systemic Health

Eubacterium rectale is strongly associated with metabolic homeostasis. A reduction in its abundance is observed in patients with type 2 diabetes mellitus (T2DM), including pregnant women with pregestational T2DM, where it is negatively correlated with glycemic traits. Conversely, in certain contexts like Metabolic Associated Fatty Liver Disease (MAFLD), an increase in E. rectale is associated with non-obese MAFLD and may correlate with the degree of hepatic steatosis, potentially through increased lipid synthesis via propionic and butyric acid analogues.

Inflammation and Viral Severity

This microbe is associated with the modulation of systemic inflammation. In patients with COVID-19, a depletion of E. rectale is linked to increased concentrations of inflammatory cytokines (such as TNF-α, CXCL10, CCL2, and IL-10) and is associated with higher disease severity and increased mortality rates. Its presence is generally linked to a reduced host inflammatory response.

Oncology and Autoimmunity

The role of E. rectale in colorectal cancer (CRC) is complex; while it is often depleted in CRC-associated microbiota due to its anti-inflammatory nature, some evidence suggests that its butyrate production might promote growth in already established tumors. Additionally, its abundance has been found to negatively correlate with the Th17/Treg ratio in patients with primary Sjögren’s syndrome, suggesting an influence on autoimmune signaling.

Foods Supporting Healthy Balance

Maintaining a healthy abundance of Eubacterium rectale is primarily achieved through the consumption of non-digestible carbohydrates that serve as prebiotics. Resistant starches (Type 2) have been shown to significantly raise the proportions of this species. Additionally, concentrated raw fibers derived from pea, oat, psyllium, wheat, and apple enhance the abundance of fiber-degraders, including E. rectale, by increasing glycan-degrading enzyme activity.

The Mediterranean Diet, characterized by a high intake of minimally processed plant foods, fruits, vegetables, and fermented foods, is associated with the growth of SCFA-producing species like E. rectale. These dietary patterns support a balanced gut ecosystem, reducing inflammation and improving overall metabolic health. Conversely, diets high in animal products and low in plant polysaccharides are associated with a decrease in E. rectale levels.

Actionable Insights

  • Prioritize Prebiotic Fibers: Incorporate foods rich in resistant starches and raw plant fibers (such as oats, apples, and legumes) to provide the necessary substrates for E. rectale fermentation.
  • Adopt Plant-Forward Eating: Shifting toward a Mediterranean-style diet may help maintain the abundance of beneficial SCFA producers and support cardiovascular and metabolic health.
  • Support Diversity: Use fermented foods and varied plant sources to encourage a diverse microbial network, which helps prevent the dysbiosis associated with inflammatory conditions.
  • Mindful Medication Use: Be aware that certain medications, such as metformin, have been associated with an increase in E. rectale abundance in some populations, highlighting the interaction between pharmacology and the microbiome.

Conclusion

Eubacterium rectale serves as a cornerstone of the healthy gut ecosystem, primarily through its functional potential to produce butyrate. This metabolite is essential for maintaining the gut barrier and regulating systemic inflammation. While typically beneficial, its impact is niche-dependent; for example, its role in established tumors or specific metabolic disorders like MAFLD suggests that the balance of its abundance is more critical than simple presence. By supporting this microbe through prebiotic-rich nutrition, individuals can promote a resilient gut environment associated with reduced inflammation and improved metabolic stability.


Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.